3,4-methylenedioxyamphetamine has been researched along with Hyponatremia in 3 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Hyponatremia: Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maxwell, DL | 1 |
| Polkey, MI | 1 |
| Henry, JA | 1 |
| Kessel, B | 1 |
| Holden, R | 1 |
| Jackson, MA | 1 |
3 other studies available for 3,4-methylenedioxyamphetamine and Hyponatremia
| Article | Year |
|---|---|
Hyponatraemia and catatonic stupor after taking "ecstasy".
Topics: 3,4-Methylenedioxyamphetamine; Adolescent; Catatonia; Designer Drugs; Female; Humans; Hyponatremia; | 1993 |
Hyponatraemia after ingestion of ecstasy.
Topics: 3,4-Methylenedioxyamphetamine; Adult; Designer Drugs; Female; Humans; Hyponatremia; N-Methyl-3,4-met | 1994 |
Near-fatal hyponatraemic coma due to vasopressin over-secretion after "ecstasy" (3,4-MDMA)
Topics: 3,4-Methylenedioxyamphetamine; Adult; Coma; Hallucinogens; Humans; Hyponatremia; Male; Serotonin Age | 1996 |